MCM
OPTR

Moore Capital Management’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Moore Capital Management’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-200,000
Closed -$2.52M – 512
2013
Q3 		$2.52M Buy
+200,000
New +$2.65M 0.05% 222

Moore Capital Management's OPTR Position: Q4 2013 in Review

Moore Capital Management sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 200,000 shares — an estimated $2.52M sold.

Moore Capital Management first reported a position in OPTR in Q3 2013 and held it in 1 quarter. The position peaked at $2.52M in Q3 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Moore Capital Management reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Moore Capital Management sold 200,000 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $2.52M.
  • Moore Capital Management first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q3 2013 and held it in 1 quarter.
  • Moore Capital Management's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $2.52M in Q3 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Moore Capital Management's 13F filing for Q4 2013, filed 14 Feb 2014.